The National Coalition for Cancer Survivorship’s Cancer Policy Advisors are an appointed group of leaders in the oncology field including leading researchers, oncologists, scholars, payers, and cancer center and survivorship program directors, who will provide guidance to NCCS as it represents cancer patients and survivors on policy issues related to cancer care delivery, payment, and quality improvement.

NCCS Cancer Policy Advisors

Stuart M. Butler, PhD
Distinguished Fellow and Director
Center for Policy Innovation
The Heritage Foundation

John V. Cox, DO
Texas Oncology

Mr. Bob Erwin
Marti Nelson Cancer Foundation

Scott Gottlieb, MD
Resident Scholar
American Enterprise Institute

Pamela (P.J.) Haylock, RN 

Michael Kolodziej, MD
National Medical Director
Aetna Oncology Strategies

Michael Link, MD
Lydia J. Lee Professor in Pediatric Cancer
Stanford Cancer Institute

Jennifer Malin, MD
Medical Director, Oncology
WellPoint, Inc.

Mary McCabe, RN, MN
Director, Cancer Survivorship Initiative
Memorial Sloan-Kettering Cancer Center

Therese M. Mulvey, MD, FASCO
Physician-in-Chief
Southcoast Centers for Cancer Care

Lee Newcomer, MD
Senior Vice President
UnitedHealthcare

Kevin C. Oeffinger, MD
Director, Adult Long-Term Follow-Up Program
Memorial Sloan-Kettering Cancer Center

Ann H. Partridge, MD, MPH
Associate Professor, Department of Medicine,
Harvard Medical School
Active Medical Staff, Medical Oncology
Dana-Farber Cancer Institute

Kavita Patel, MD
Managing Director for Clinical Transformation and Delivery
Engelberg Center for Health Care Reform
Brookings Institution

Derek Raghavan, MD, PhD, FACP, FRACP
President
Levine Cancer Institute

Jeffrey Scott, MD
Strategic Oncology Consultants

Thomas Smith, MD
The Harry J. Duffey Family Professor of Palliative Medicine
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins University

Jennifer S. Temel, M.D.
Clinical Director of Thoracic Oncology
Massachusetts General Hospital